Coenzyme Q: Clinical Applications in Cardiovascular Diseases

Overview

Journal Antioxidants (Basel)

Date 2020 Apr 26

PMID 32331285

Citations 41

Authors

Alma Martelli

Lara Testai

Alessandro Colletti

Arrigo F G Cicero

Affiliations

Soon will be listed here.

Abstract

Coenzyme Q (CoQ) is a ubiquitous factor present in cell membranes and mitochondria, both in its reduced (ubiquinol) and oxidized (ubiquinone) forms. Its levels are high in organs with high metabolism such as the heart, kidneys, and liver because it acts as an energy transfer molecule but could be reduced by aging, genetic factors, drugs (e.g., statins), cardiovascular (CV) diseases, degenerative muscle disorders, and neurodegenerative diseases. As CoQ is endowed with significant antioxidant and anti-inflammatory features, useful to prevent free radical-induced damage and inflammatory signaling pathway activation, its depletion results in exacerbation of inflammatory processes. Therefore, exogenous CoQ supplementation might be useful as an adjuvant in the treatment of cardiovascular diseases such as heart failure, atrial fibrillation, and myocardial infarction and in associated risk factors such as hypertension, insulin resistance, dyslipidemias, and obesity. This review aims to summarize the current evidences on the use of CoQ supplementation as a therapeutic approach in cardiovascular diseases through the analysis of its clinical impact on patients' health and quality of life. A substantial reduction of inflammatory and oxidative stress markers has been observed in several randomized clinical trials (RCTs) focused on several of the abovementioned diseases, even if more RCTs, involving a larger number of patients, will be necessary to strengthen these interesting findings.

Citing Articles

Can Coenzyme Q10 Supplementation Reduce Cardiovascular Disease Risk Factors? A Protocol for a GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.

Jafari A Health Sci Rep. 2025; 8(2):e70452.

PMID: 39931258 PMC: 11808257. DOI: 10.1002/hsr2.70452.

Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach.

Mauriello A, Correra A, Molinari R, Del Vecchio G, Tessitore V, DAndrea A Biomedicines. 2025; 12(12.

PMID: 39767627 PMC: 11727148. DOI: 10.3390/biomedicines12122720.

Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition.

Pokushalov E, Ponomarenko A, Shrainer E, Kudlay D, Miller R Nutrients. 2024; 16(23).

PMID: 39683427 PMC: 11643751. DOI: 10.3390/nu16234033.

The effect of coenzyme Q10 pretreatment on ovarian reserve in women undergoing hysterectomy with bilateral salpingectomy: a randomised, double-blind, placebo-controlled trial.

Micaraseth K, Tantanavipas S, Hongsakorn W, Singwongsa A Br J Nutr. 2024; 133(2):213-220.

PMID: 39648702 PMC: 11813623. DOI: 10.1017/S0007114524003131.

Mitochondrial Stress as a Central Player in the Pathogenesis of Hypoxia-Related Myocardial Dysfunction: New Insights.

Guo Z, Tian Y, Liu N, Chen Y, Chen X, Yuan G Int J Med Sci. 2024; 21(13):2502-2509.

PMID: 39439461 PMC: 11492880. DOI: 10.7150/ijms.99359.

References

Tenorio M, Ferreira R, Moura F, Bueno N, Goulart M, Oliveira A . Oral antioxidant therapy for prevention and treatment of preeclampsia: Meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2018; 28(9):865-876. DOI: 10.1016/j.numecd.2018.06.002. View

Bhagavan H, Chopra R . Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006; 40(5):445-53. DOI: 10.1080/10715760600617843. View

Chen K, Chen X, Xue H, Zhang P, Fang W, Chen X . Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway. Food Funct. 2019; 10(2):814-823. DOI: 10.1039/c8fo01236a. View

Ignarro L . Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989; 65(1):1-21. DOI: 10.1161/01.res.65.1.1. View

DI Pierro F, Rossi A, Consensi A, Giacomelli C, Bazzichi L . Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clin Exp Rheumatol. 2016; 35 Suppl 105(3):20-27. View

Bakhshayeshkaram M, Lankarani K, Mirhosseini N, Tabrizi R, Akbari M, Dabbaghmanesh M . The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Curr Pharm Des. 2018; 24(31):3710-3723. DOI: 10.2174/1381612824666181112112857. View

Lopez-Lluch G, Del Pozo-Cruz J, Sanchez-Cuesta A, Cortes-Rodriguez A, Navas P . Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2018; 57:133-140. DOI: 10.1016/j.nut.2018.05.020. View

Mourier A, Motori E, Brandt T, Lagouge M, Atanassov I, Galinier A . Mitofusin 2 is required to maintain mitochondrial coenzyme Q levels. J Cell Biol. 2015; 208(4):429-42. PMC: 4332246. DOI: 10.1083/jcb.201411100. View

Reis Geovanini G, Libby P . Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018; 132(12):1243-1252. DOI: 10.1042/CS20180306. View

10.

Cordero M, Cano-Garcia F, Alcocer-Gomez E, de Miguel M, Sanchez-Alcazar J . Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement. PLoS One. 2012; 7(4):e35677. PMC: 3330812. DOI: 10.1371/journal.pone.0035677. View

11.

Mehmetoglu I, Yerlikaya F, Kurban S, Erdem S, Tonbul Z . Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin. Int J Artif Organs. 2012; 35(3):226-32. DOI: 10.5301/ijao.5000078. View

12.

Soongswang J, Sangtawesin C, Durongpisitkul K, Laohaprasitiporn D, Nana A, Punlee K . The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatr Cardiol. 2005; 26(4):361-6. DOI: 10.1007/s00246-004-0742-1. View

13.

Samimi M, Zarezade Mehrizi M, Foroozanfard F, Akbari H, Jamilian M, Ahmadi S . The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2016; 86(4):560-566. DOI: 10.1111/cen.13288. View

14.

Hernandez-Alvarez M, Sebastian D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P . Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell. 2019; 177(4):881-895.e17. DOI: 10.1016/j.cell.2019.04.010. View

15.

Lee Y, Cho W, Kim J, Lee D . Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study. J Med Food. 2011; 14(4):386-90. DOI: 10.1089/jmf.2010.1202. View

16.

Lim S, Lekshminarayanan R, Goh S, Ong Y, Subramaniam T, Sum C . The effect of coenzyme Q10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus. Atherosclerosis. 2008; 196(2):966-9. DOI: 10.1016/j.atherosclerosis.2007.11.012. View

17.

Langsjoen P, Langsjoen A, Willis R, Folkers K . Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Mol Aspects Med. 1997; 18 Suppl:S145-51. DOI: 10.1016/s0098-2997(97)00006-x. View

18.

Fogacci S, Fogacci F, Cicero A . Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence. Nutrients. 2020; 12(2). PMC: 7071166. DOI: 10.3390/nu12020378. View

19.

Folkers K, Vadhanavikit S, Mortensen S . Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A. 1985; 82(3):901-4. PMC: 397155. DOI: 10.1073/pnas.82.3.901. View

20.

Martinefski M, Samassa P, Buontempo F, Hocht C, Lucangioli S, Tripodi V . Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy. J Pharm Pharmacol. 2016; 69(5):567-573. DOI: 10.1111/jphp.12613. View